UNSPSC 51352402: Chlordiazepoxide/estrogens

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class HS300. This VA Drug Class (HS300) classifies this compound as belonging to the group ESTROGENS.

UNSPSC 51352402 Chlordiazepoxide/estrogens (Commodity) covers pharmaceutical combination products pairing the benzodiazepine anxiolytic chlordiazepoxide with estrogen compounds, historically used in hormone replacement and anxiety management. State and local governments procure this medication primarily through health departments, correctional facilities, public health clinics, and state Medicaid programs that serve low-income and institutionalized populations. The code represents a narrow, legacy pharmaceutical product line; modern procurement has largely shifted toward separate-fill protocols or updated hormone therapies, making this combination less common in recent state and local purchasing.

The source provided contains no records of recent state or local contract opportunities under UNSPSC 51352402. The code shows no recent solicitation activity in available procurement databases, suggesting minimal current demand for this specific pharmaceutical combination at the state and local level.